Weissen announced that it will participate in 'Arab Health 2025' held in Dubai from the 27th to the 30th.
In this exhibition, Weissen will present 'WAYMED ENDO', an AI-based gastrointestinal/colonoscopy software. This software is linked to gastrointestinal/colonoscopy equipment, analyzes endoscopic images in real time, and has the function of quickly and accurately detecting abnormal lesions in the stomach and colon. In particular, it has the great advantage of assisting endoscopic examinations so as not to miss blind spots or minute lesions, and is being rapidly introduced in hospitals at home and abroad.
Through this exhibition, Weysen plans to actively meet with partners in the Middle East market and seek ways to expand its business in the Middle East. In addition, it plans to meet with hospital officials and global medical company leaders in the Middle East to discuss strategic cooperation plans for 'Waymed Endo'. Weysen has already signed a strategic sales contract with Saudi Arabian medical company 'Megamind' at the last Arab Health exhibition.
The Middle East, especially the UAE, has a large population suffering from digestive diseases such as acid reflux and ulcerative colitis, and the prevalence of colon cancer is the second highest among all cancers. Accordingly, the demand for gastrointestinal/colonoscopy examinations is rapidly increasing. Weysen has been installing and operating 'WayMed Endo' in the first local hospital in the UAE since 2023, and is securing clinical effectiveness as a medical AI software suitable for the UAE medical environment through feedback from local medical staff.
Meanwhile, Arab Health is celebrating its 50th anniversary this year and is receiving even greater attention. Every year, more than 60,000 hospital staff and buyers participate to share the latest medical technology trends and business information.
- See more related articles
You must be logged in to post a comment.